The Niche Episode 077 – Johnson & Johnson, Organon, Medicare, PharmaEssentia, Arbor Biotechnologies, Glen de Vries

A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacy

Find out more at

Story References
Johnson & Johnson
Arbor Biotechnologies
Glen de Vries

Music by Luke Goodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.



Registered Users

Please login or register to continue.